Chiron Investment Management, LLC Merck & Co., Inc. Transaction History

Chiron Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$123.8 - $132.96 $6.72 Million - $7.22 Million	54,265 New	54,265 $6.72 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $7.59 Million - $8.43 Million	73,700 Added 219.01%	107,351 $11.1 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $3.65 Million - $3.98 Million	33,651 New	33,651 $3.88 Million
Q2 2017 Aug 15, 2017	SELL	N/A	-79,400 Closed	0 $0
Q1 2017 Aug 15, 2017	BUY	N/A	79,400	79,400 $5.05 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Chiron Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Chiron Investment Management, LLC with notifications on news.